ImageneBio (IMA) Equity Ratio (2020 - 2024)
Historic Equity Ratio for ImageneBio (IMA) over the last 5 years, with Q3 2024 value amounting to 0.9.
- ImageneBio's Equity Ratio rose 2488.92% to 0.9 in Q3 2024 from the same period last year, while for Sep 2024 it was 0.9, marking a year-over-year increase of 2488.92%. This contributed to the annual value of 0.88 for FY2023, which is 357.97% up from last year.
- As of Q3 2024, ImageneBio's Equity Ratio stood at 0.9, which was up 2488.92% from 0.91 recorded in Q2 2024.
- In the past 5 years, ImageneBio's Equity Ratio ranged from a high of 0.91 in Q2 2023 and a low of 0.6 during Q4 2020
- Over the past 5 years, ImageneBio's median Equity Ratio value was 0.84 (recorded in 2021), while the average stood at 0.75.
- Per our database at Business Quant, ImageneBio's Equity Ratio skyrocketed by 23976.27% in 2021 and then plummeted by 1346.65% in 2023.
- Quarter analysis of 5 years shows ImageneBio's Equity Ratio stood at 0.6 in 2020, then surged by 239.76% to 0.84 in 2021, then grew by 1.74% to 0.85 in 2022, then rose by 3.58% to 0.88 in 2023, then rose by 1.95% to 0.9 in 2024.
- Its Equity Ratio stands at 0.9 for Q3 2024, versus 0.91 for Q2 2024 and 0.9 for Q1 2024.